Page 1 | Search Results | Blood | American Society of Hematology

1-13 of 13

Sort by

Sort Order Select

Journal Articles

Single-Agent Ibrutinib Vs Chemoimmunotherapy Regimens for Treatment-Naïve Patients with Chronic Lymphocytic Leukemia (CLL): A Cross-Trial Comparison

Blood (2017) 130 (Supplement 1): 1750.

https://doi.org/10.1182/blood.V130.Suppl_1.1750.1750

Published: 2017

Journal Articles

Epigenetic Biomarkers Are Applicable for Risk Stratification in Myelodysplastic Syndromes

Anna Mies, Tanja Božić, Michael Kramer, Julia Franzen, Gerhard Ehninger, Martin Bornhäuser, Uwe Platzbecker, Wolfgang Wagner

Blood (2016) 128 (22): 3194.

https://doi.org/10.1182/blood.V128.22.3194.3194

Published: 2016

Journal Articles

Impact of Dose-Difference in Comparator Arms Among Clinical Trials on Treatment Effect Size in a Network Meta-Analysis: A Case of First-Line Therapies in Chronic Lymphocytic Leukemia (CLL)

Mkaya Mwamburi, PhD MD MA, Vasudha Bal, MSc, MBA, Teresa Cascella, MD, Anshul Shah, B.Pharm, MS, Merena Nanavaty, B. Pharm, MS, Smeet Gala, B.Tech, MS

Blood (2016) 128 (22): 5593.

https://doi.org/10.1182/blood.V128.22.5593.5593

Published: 2016

Journal Articles

Comparative Effectiveness of Ofatumumab (O) in Combination with Chlorambucil (Chl) Versus Bendamustine (B), and Obinutuzumab (GA101) or Rituximab (R) in Combination with Chlorambucil for Chronic Lymphocytic Leukaemia (CLL)

Sorrel E Wolowacz, PhD, Sarah Mitchell, Amin Haiderali

Blood (2014) 124 (21): 5993.

https://doi.org/10.1182/blood.V124.21.5993.5993

Published: 2014

Journal Articles

Cost-Effectiveness Analysis of Obinutuzumab Versus Ofatumumab for Previously Untreated Chronic Lymphocytic Leukemia (CLL)

Carolina Reyes, PhD, Gregory Gazauskas, PhD, Ursula Becker, MSc, Santiago Moreno, David L. Veenstra, PharmD, PhD

Blood (2014) 124 (21): 1324.

https://doi.org/10.1182/blood.V124.21.1324.1324

Published: 2014

Journal Articles

NOTCH1 Mutation and Treatment Outcome In CLL Patients Treated With Chlorambucil (Chl) Or Ofatumumab-Chl (O-Chl): Results From The Phase III Study Complement 1 (OMB110911)

Eugen Tausch, MD, Philipp Beck, Richard F. Schlenk, MD, Sabrina Kless, Christina Galler, Peter Hillmen, MB ChB, PhD, Fritz Offner, MD, Ann Janssens, MD, K Govindbabu, MD, Sebastian Grosicki, MD, Jiri Mayer, MD, PhD, Panagiotis Panagiotidis, MD, Susanne Danhauser-Riedl, MD, Astrid McKeown, PhD, Paul D P´B Winter, PhD, Ira V Gupta, MD, Hartmut Döhner, MD, Stephan Stilgenbauer, MD

Blood (2013) 122 (21): 527.

https://doi.org/10.1182/blood.V122.21.527.527

Published: 2013

Journal Articles

Ofatumumab + Chlorambucil Versus Chlorambucil Alone In Patients With Untreated Chronic Lymphocytic Leukemia (CLL): Results Of The Phase III Study Complement 1 (OMB110911)

Peter Hillmen, MB ChB, PhD, Tadeusz Robak, Ann Janssens, MD, K Govindbabu, MD, Sebastian Grosicki, MD, Jiri Mayer, MD, PhD, Panagiotis Panagiotidis, MD, Eva Kimby, MD, Anna Schuh, MD, Thomas Boyd, MD, Marco Montillo, MD, Astrid McKeown, PhD, Jodi L Carey, RN, BSN, Ira V Gupta, MD, Chai-Ni Chang, MS, Steen Lisby, MD, DMSc, Fritz Offner, MD

Blood (2013) 122 (21): 528.

https://doi.org/10.1182/blood.V122.21.528.528

Published: 2013

Journal Articles

The Diffuse Large B-Cell Lymphoma Infiltrating Macrophage Transcriptome Signature Is Enriched for Both M1 and M2 Genes and Provides an Excellent Platform for Functional Validation of Macrophage Biology in DLBCL

Rita Coutinho, MD, Aaron M. Newman, PhD, Guglielmo Rossignoli, PhD, William Day, MsC, Faridah Miraki-Moud, PhD, Tracy Chaplin, Jacek Marzec, Robert D. Petty, Sameena Iqbal, Janet Matthews, Ash A. Alizadeh, MD, PhD, John G Gribben

Blood (2012) 120 (21): 790.

https://doi.org/10.1182/blood.V120.21.790.790

Published: 2012

Journal Articles

Mesenchymal Stem Cells Express the Surface Receptor Calreticulin (cC1qR) and Complement C1q Chemoattracts Them.

Yuanyuan Qiu, PhD, Leah A. Marquez-Curtis, PhD, Anna Janowska-Wieczorek, MD, PhD

Blood (2010) 116 (21): 3855.

https://doi.org/10.1182/blood.V116.21.3855.3855

Published: 2010

Journal Articles

An Ex Vivo Perfusion Model To Study the Treatment of Thrombotic Microangiopathy during Pig-to-Human Xenogenic Kidney Transplantation.

Wolf Ramackers, Lars Friedrich, MD, Wolfgang Schüttler, PhD, Sabine Bergmann, Arnold Ganser, MD, Michael Winkler, MD, Andreas Tiede, MD, PhD

Blood (2007) 110 (11): 3190.

https://doi.org/10.1182/blood.V110.11.3190.3190

Published: 2007

Journal Articles

Hematopoietic Progenitors with Slow Divisional Kinetics Give Rise to T Cell Precursors in the Thymus of the SCID Mouse Transplantation Model and Represent the Subset with Primitive Function.

Mario Schubert, MD, Margot Zoeller, MD, PhD, Wolfgang Wagner, MD, PhD, Patrick Wuchter, MD, Volker Eckstein, PhD, Anthony D. Ho, MD

Blood (2007) 110 (11): 2232.

https://doi.org/10.1182/blood.V110.11.2232.2232

Published: 2007

Journal Articles

Missense Mutations in the Proline-Rich Region of Coagulation Factor XII in Hereditary and Idiopathic Angioedema.

Georg Dewald, MD, Konrad Bork, M.D.

Blood (2006) 108 (11): 1619.

https://doi.org/10.1182/blood.V108.11.1619.1619

Published: 2006

Journal Articles

Interaction of Stem Cells and Their Niche: Behavior and Gene Expression Profiles of CD34+/CD38− Cells upon Co-Cultivation with AFT024.

Wolfgang Wagner, MD, Rainer Saffrich, PhD, Ute Wirkner, PhD, Volker Eckstein, PhD, Jonathon Blake, PhD, Alexandra Ansorge, MD, Christian Schwager, PhD, Katrin Miesala, Wilhelm Ansorge, PhD, Anthony D. Ho, MD

Blood (2004) 104 (11): 1281.

https://doi.org/10.1182/blood.V104.11.1281.1281

Published: 2004

NARROW

Single-Agent Ibrutinib Vs Chemoimmunotherapy Regimens for Treatment-Naïve Patients with Chronic Lymphocytic Leukemia (CLL): A Cross-Trial Comparison

Epigenetic Biomarkers Are Applicable for Risk Stratification in Myelodysplastic Syndromes

Impact of Dose-Difference in Comparator Arms Among Clinical Trials on Treatment Effect Size in a Network Meta-Analysis: A Case of First-Line Therapies in Chronic Lymphocytic Leukemia (CLL)

Comparative Effectiveness of Ofatumumab (O) in Combination with Chlorambucil (Chl) Versus Bendamustine (B), and Obinutuzumab (GA101) or Rituximab (R) in Combination with Chlorambucil for Chronic Lymphocytic Leukaemia (CLL)

Cost-Effectiveness Analysis of Obinutuzumab Versus Ofatumumab for Previously Untreated Chronic Lymphocytic Leukemia (CLL)

NOTCH1 Mutation and Treatment Outcome In CLL Patients Treated With Chlorambucil (Chl) Or Ofatumumab-Chl (O-Chl): Results From The Phase III Study Complement 1 (OMB110911)

Ofatumumab + Chlorambucil Versus Chlorambucil Alone In Patients With Untreated Chronic Lymphocytic Leukemia (CLL): Results Of The Phase III Study Complement 1 (OMB110911)

The Diffuse Large B-Cell Lymphoma Infiltrating Macrophage Transcriptome Signature Is Enriched for Both M1 and M2 Genes and Provides an Excellent Platform for Functional Validation of Macrophage Biology in DLBCL

Mesenchymal Stem Cells Express the Surface Receptor Calreticulin (cC1qR) and Complement C1q Chemoattracts Them.

An Ex Vivo Perfusion Model To Study the Treatment of Thrombotic Microangiopathy during Pig-to-Human Xenogenic Kidney Transplantation.

Hematopoietic Progenitors with Slow Divisional Kinetics Give Rise to T Cell Precursors in the Thymus of the SCID Mouse Transplantation Model and Represent the Subset with Primitive Function.

Missense Mutations in the Proline-Rich Region of Coagulation Factor XII in Hereditary and Idiopathic Angioedema.

Interaction of Stem Cells and Their Niche: Behavior and Gene Expression Profiles of CD34+/CD38− Cells upon Co-Cultivation with AFT024.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only